262 related articles for article (PubMed ID: 31501586)
1. Perspectives of US private payers on insurance coverage for pediatric and prenatal exome sequencing: Results of a study from the Program in Prenatal and Pediatric Genomic Sequencing (P3EGS).
Trosman JR; Weldon CB; Slavotinek A; Norton ME; Douglas MP; Phillips KA
Genet Med; 2020 Feb; 22(2):283-291. PubMed ID: 31501586
[TBL] [Abstract][Full Text] [Related]
2. Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.
Douglas MP; Parker SL; Trosman JR; Slavotinek AM; Phillips KA
Genet Med; 2019 Jan; 21(1):152-160. PubMed ID: 29997388
[TBL] [Abstract][Full Text] [Related]
3. US private payers' perspectives on insurance coverage for genome sequencing versus exome sequencing: A study by the Clinical Sequencing Evidence-Generating Research Consortium (CSER).
Phillips KA; Trosman JR; Douglas MP; Gelb BD; Ferket BS; Hindorff LA; Slavotinek AM; Berg JS; Russell HV; Devine B; Greve V; Smith HS
Genet Med; 2022 Jan; 24(1):238-244. PubMed ID: 34906461
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Exome Sequencing Criteria for Hospital Stewardship and Insurance Authorization at a Pediatric Hospital.
Wittowski CL; Clowes Candadai S; Perrone ME; Gallego DF; Conta JH; Dickerson JA
Arch Pathol Lab Med; 2022 Jan; 146(1):107-111. PubMed ID: 33836053
[TBL] [Abstract][Full Text] [Related]
5. Exome Sequencing for Prenatal Detection of Genetic Abnormalities in Fetal Ultrasound Anomalies: An Economic Evaluation.
Kodabuckus SS; Quinlan-Jones E; McMullan DJ; Maher ER; Hurles ME; Barton PM; Kilby MD
Fetal Diagn Ther; 2020; 47(7):554-564. PubMed ID: 31962312
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: a randomized controlled trial.
Staley BS; Milko LV; Waltz M; Griesemer I; Mollison L; Grant TL; Farnan L; Roche M; Navas A; Lightfoot A; Foreman AKM; O'Daniel JM; O'Neill SC; Lin FC; Roman TS; Brandt A; Powell BC; Rini C; Berg JS; Bensen JT
Trials; 2021 Jun; 22(1):395. PubMed ID: 34127041
[TBL] [Abstract][Full Text] [Related]
7. Optimising Exome Prenatal Sequencing Services (EXPRESS): a study protocol to evaluate rapid prenatal exome sequencing in the NHS Genomic Medicine Service.
Hill M; Ellard S; Fisher J; Fulop N; Knight M; Kroese M; Ledger J; Leeson-Beevers K; McEwan A; McMullan D; Mellis R; Morris S; Parker M; Tapon D; Baple E; Blackburn L; Choudry A; Lafarge C; McInnes-Dean H; Peter M; Ramakrishnan R; Roberts L; Searle B; Smith E; Walton H; Wynn SL; Han Wu W; Chitty LS
NIHR Open Res; 2022; 2():10. PubMed ID: 35935673
[TBL] [Abstract][Full Text] [Related]
8. A single center experience with publicly funded clinical exome sequencing for neurodevelopmental disorders or multiple congenital anomalies.
Pode-Shakked B; Barel O; Singer A; Regev M; Poran H; Eliyahu A; Finezilber Y; Segev M; Berkenstadt M; Yonath H; Reznik-Wolf H; Gazit Y; Chorin O; Heimer G; Gabis LV; Tzadok M; Nissenkorn A; Bar-Yosef O; Zohar-Dayan E; Ben-Zeev B; Mor N; Kol N; Nayshool O; Shimshoviz N; Bar-Joseph I; Marek-Yagel D; Javasky E; Einy R; Gal M; Grinshpun-Cohen J; Shohat M; Dominissini D; Raas-Rothschild A; Rechavi G; Pras E; Greenbaum L
Sci Rep; 2021 Sep; 11(1):19099. PubMed ID: 34580403
[TBL] [Abstract][Full Text] [Related]
9. Payer Coverage for Hereditary Cancer Panels: Barriers, Opportunities, and Implications for the Precision Medicine Initiative.
Trosman JR; Weldon CB; Douglas MP; Kurian AW; Kelley RK; Deverka PA; Phillips KA
J Natl Compr Canc Netw; 2017 Feb; 15(2):219-228. PubMed ID: 28188191
[No Abstract] [Full Text] [Related]
10. Insurers Reluctant to Cover Prenatal Exome Sequencing.
Am J Med Genet A; 2020 May; 182(5):950-951. PubMed ID: 32304189
[No Abstract] [Full Text] [Related]
11. Access to prenatal exome sequencing for fetal malformations: A qualitative landscape analysis in the US.
Sahin-Hodoglugil NN; Lianoglou BR; Ackerman S; Sparks TN; Norton ME
Prenat Diagn; 2023 Oct; 43(11):1394-1405. PubMed ID: 37752660
[TBL] [Abstract][Full Text] [Related]
12. Application of exome sequencing for prenatal diagnosis: a rapid scoping review.
Pratt M; Garritty C; Thuku M; Esmaeilisaraji L; Hamel C; Hartley T; Millar K; Skidmore B; Dougan S; Armour CM
Genet Med; 2020 Dec; 22(12):1925-1934. PubMed ID: 32747765
[TBL] [Abstract][Full Text] [Related]
13. Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.
Reuter CM; Kohler JN; Bonner D; Zastrow D; Fernandez L; Dries A; Marwaha S; Davidson J; Brokamp E; Herzog M; Hong J; Macnamara E; Rosenfeld JA; Schoch K; Spillmann R; ; Loscalzo J; Krier J; Stoler J; Sweetser D; Palmer CGS; Phillips JA; Shashi V; Adams DA; Yang Y; Ashley EA; Fisher PG; Mulvihill JJ; Bernstein JA; Wheeler MT
J Genet Couns; 2019 Dec; 28(6):1107-1118. PubMed ID: 31478310
[TBL] [Abstract][Full Text] [Related]
14. Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.
Trosman JR; Weldon CB; Kelley RK; Phillips KA
J Natl Compr Canc Netw; 2015 Mar; 13(3):311-8. PubMed ID: 25736008
[TBL] [Abstract][Full Text] [Related]
15. Challenges in variant interpretation in prenatal exome sequencing.
Basel-Salmon L; Sukenik-Halevy R
Eur J Med Genet; 2022 Feb; 65(2):104410. PubMed ID: 34952236
[TBL] [Abstract][Full Text] [Related]
16. Improving access to exome sequencing in a medically underserved population through the Texome Project.
Vuocolo B; German RJ; Lalani SR; Murali CN; Bacino CA; Baskin S; Littlejohn R; Odom JD; McLean S; Schmid C; Nutter M; Stuebben M; Magness E; Juarez O; El Achi D; Mitchell B; Glinton KE; Robak L; Nagamani SCS; Saba L; Ritenour A; Zhang L; Streff H; Chan K; Kemere KJ; Carter K; ; Owen N; Vossaert L; Liu P; Bellen H; Wangler MF
Genet Med; 2024 Jun; 26(6):101102. PubMed ID: 38431799
[TBL] [Abstract][Full Text] [Related]
17. Implementation of Exome Sequencing in Prenatal Diagnosis and Impact on Genetic Counseling: The Polish Experience.
Kucińska-Chahwan A; Geremek M; Roszkowski T; Bijok J; Massalska D; Ciebiera M; Correia H; Pereira-Caetano I; Barreta A; Obersztyn E; Kutkowska-Kaźmierczak A; Własienko P; Krajewska-Walasek M; Węgrzyn P; Dudarewicz L; Krzeszowski W; Rybak-Krzyszkowska M; Nowakowska B
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627109
[TBL] [Abstract][Full Text] [Related]
18. Genetics professionals' attitudes toward prenatal exome sequencing.
Brew CE; Castro BA; Pan V; Hart A; Blumberg B; Wicklund C
J Genet Couns; 2019 Apr; 28(2):229-239. PubMed ID: 30888706
[TBL] [Abstract][Full Text] [Related]
19. [A consensus recommendation for the interpretation and reporting of exome sequencing in prenatal genetic diagnosis].
Genetic Disease Society Guangdong Precision Medicine Application Association Prenatal Diagnosis Group Maternal And Child Health Care Society Guangdong Medical Association Expert Committee Of Prenatal Diagnosis ; Zhang Y; Liu W; Zhang J; Lin S; Huang H; Zhang WV; Ren Z; Wang Y; Yang Y; Yin A
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Nov; 37(11):1205-1212. PubMed ID: 33179222
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of private payers on multicancer early-detection tests: informing research, implementation, and policy.
Trosman JR; Weldon CB; Kurian AW; Pasquinelli MM; Kircher SM; Martin N; Douglas MP; Phillips KA
Health Aff Sch; 2023 Jul; 1(1):qxad005. PubMed ID: 38756840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
